Create Technology & Science Co Debt/EBITDA
The Total Debt to EBITDA Ratio of Create Technology & Science Co (000551.SZ) as of Sep 2, 2026 is 1.19. In the previous year, Total Debt to EBITDA Ratio was 2.19 — a change of -45.53% (lower).
Get this data via API
Financial Data API
Debt/EBITDA
1.19
YoY
-45.53%
Last updated:
The Create Technology & Science Co Debt/EBITDA history
3 Years
10 Years
25 Years
Max
| YEAR | Debt/EBITDA | YoY |
|---|---|---|
| 1.19 | -45.53% | |
| 2.19 | -4.96% | |
| 2.30 | -30.12% | |
| 3.30 | +20.91% | |
| 2.73 | -15.57% | |
| 3.23 | -22.42% | |
| 4.16 | +15.42% | |
| 3.61 | -23.59% | |
| 4.72 | -24.04% | |
| 6.21 | +49.33% | |
| 4.16 | — |
Create Technology & Science Co Stock analysis
Frequently Asked Questions about Create Technology & Science Co stock
Total Debt to EBITDA Ratio of Create Technology & Science Co is 1.19 in 2026.
Total Debt to EBITDA Ratio of Create Technology & Science Co changed from 2.19 to 1.19, representing a -45.53% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio Create Technology & Science Co since 2006 – with annual values, charts, and detailed analysis.
Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.
A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's Create Technology & Science Co with sector peers and the industry average to assess whether it is attractive.
Leverage — Create Technology & Science Co
All Key Metrics — Create Technology & Science Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth